Pharmacologyx Research Limited - Period Ending 2023-05-31
Pharmacologyx Research Limited - Period Ending 2023-05-31
Registration number:
Pharmacologyx Research Limited
for the Year Ended 31 May 2023
Pharmacologyx Research Limited
Contents
|
Company Information |
|
|
Balance Sheet |
|
|
Notes to the Unaudited Financial Statements |
Pharmacologyx Research Limited
Company Information
|
Director |
Sivakumar Subramania Pilla |
|
Registered office |
|
|
Accountants |
|
Pharmacologyx Research Limited
(Registration number: 08518714)
Balance Sheet as at 31 May 2023
|
2023 |
2022 |
|
|
Fixed assets |
|
|
|
Current assets |
|
|
|
Creditors: Amounts falling due within one year |
( |
( |
|
Net current assets |
|
|
|
Total assets less current liabilities |
|
|
|
Creditors: Amounts falling due after more than one year |
( |
( |
|
Accruals and deferred income |
( |
( |
|
( |
( |
|
|
Capital and reserves |
( |
( |
|
General information |
The company is a private company limited by share capital, incorporated in England and Wales.
The address of its registered office is:
England
These financial statements were authorised for issue by the
Basis of preparation
These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).
|
Staff numbers |
The average number of persons employed by the company (including the director) during the year, was
For the financial year ending 31 May 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Director's responsibilities:
Pharmacologyx Research Limited
(Registration number: 08518714)
Balance Sheet as at 31 May 2023
|
• |
|
|
• |
The director acknowledges their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts. |
These financial statements have been prepared in accordance with the micro-entity provisions of the Companies Act 2006 and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the director has not delivered to the registrar a copy of the Profit and Loss Account.
Approved and authorised by the
|
......................................... |